Jamie Platt - 12 Jun 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Maria Zannes, as attorney-in-fact for Jamie Platt
Issuer symbol
BIAF
Transactions as of
12 Jun 2024
Transactions value $
$0
Form type
4
Filing time
14 Jun 2024, 20:45:56 UTC
Previous filing
24 Jan 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Award $0 +8,296 +65.49% $0 20,964 12 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately.